Dinanda J. de Jager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dinanda J. de Jager has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Friedo Wilhelm Dekker
Department of Clinical Epidemiology, Leiden University Medical Center , Leiden
4 shared publications for the NECOSAD Study Group
2 shared publicationsD. C. Grootendorst
1 shared publication- David Ansell
Quintile IMS, London, UK
1 shared publication Diana C Grootendorst
1 shared publication- Diana C Grootendorst
Department of Clinical Epidemiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, the Netherlands
1 shared publication
Latest Publications
- Open Access
- 8 January 2013
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (3) , 698-705
Is the decline of renal function different before and after the start of dialysis?
The presence of glomerular filtration in dialysis patients is associated with improved survival and quality of life. This study explores the time course of the glomerular filtration rate (GFR) between 1 year before and 1 year after the start of haemodialysis (HD) and peritoneal dialysis (PD). This study included 1861 incident dialysis patients (NECOSAD cohort; 62% male, 60 ± 15 years, 61% HD, GFR 5.2 ± 3.6 mL/min/1.73 m2). A decline of the GFR was estimated using linear mixed-effects models adjusted for age, sex, primary kidney disease, cardiovascular disease and diabetes. The rate of decline was allowed to change at a certain point in time. The decline of the GFR attenuated from −0.53 mL/min/1.73 m2/month (95% CI: −0.58, −0.48) in the period before the start of dialysis to −0.12 (95% CI: −0.20, −0.04) at 2–4 months of dialysis in all patients. In HD, decline attenuated from −0.51 (95% CI: −0.57, −0.44) to −0.14 (95% CI: −0.26, −0.02); in PD from −0.55 (95% CI: −0.62, −0.48) to −0.11 (95% CI: −0.23, 0.01). In patients who started dialysis with a GFR equal/above median GFR at dialysis start, the decline attenuated (at 3 months) from −0.70 (95% CI: −0.78; −0.62) to −0.21 (95% CI: −0.36; −0.05). In patients who started dialysis with a GFR below median GFR at dialysis start, the decline attenuated (at 1 month) from −0.73 (95% CI: −0.88; −0.58) to −0.04 (95% CI: −0.27 , 0.19). The apparent decline of the GFR slows down after 2–4 months of dialysis. This decline was similar in HD and PD patients, although at a different level of GFR. Further studies are needed to examine explanations for this phenomenon.
- 8 January 2013
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 28 (3) , 698-705
Open AccessIs the decline of renal function different before and after the start of dialysis?
The presence of glomerular filtration in dialysis patients is associated with improved survival and quality of life. This study explores the time course of the glomerular filtration rate (GFR) between 1 year before and 1 year after the start of haemodialysis (HD) and peritoneal dialysis (PD). This study included 1861 incident dialysis patients (NECOSAD cohort; 62% male, 60 ± 15 years, 61% HD, GFR 5.2 ± 3.6 mL/min/1.73 m2). A decline of the GFR was estimated using linear mixed-effects models adjusted for age, sex, primary kidney disease, cardiovascular disease and diabetes. The rate of decline was allowed to change at a certain point in time. The decline of the GFR attenuated from −0.53 mL/min/1.73 m2/month (95% CI: −0.58, −0.48) in the period before the start of dialysis to −0.12 (95% CI: −0.20, −0.04) at 2–4 months of dialysis in all patients. In HD, decline attenuated from −0.51 (95% CI: −0.57, −0.44) to −0.14 (95% CI: −0.26, −0.02); in PD from −0.55 (95% CI: −0.62, −0.48) to −0.11 (95% CI: −0.23, 0.01). In patients who started dialysis with a GFR equal/above median GFR at dialysis start, the decline attenuated (at 3 months) from −0.70 (95% CI: −0.78; −0.62) to −0.21 (95% CI: −0.36; −0.05). In patients who started dialysis with a GFR below median GFR at dialysis start, the decline attenuated (at 1 month) from −0.73 (95% CI: −0.88; −0.58) to −0.04 (95% CI: −0.27 , 0.19). The apparent decline of the GFR slows down after 2–4 months of dialysis. This decline was similar in HD and PD patients, although at a different level of GFR. Further studies are needed to examine explanations for this phenomenon.
- Open Access
- 11 August 2011
- Published by Springer Nature in BMC Nephrology
- Vol. 12 (1) , 38
Association of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: a cohort study
To investigate whether high blood pressure accelerates renal function decline in patients with advanced chronic kidney disease (CKD), we studied the association of systolic (SBP) and diastolic blood pressure (DBP) with decline in renal function and time until the start of renal replacement therapy (RRT) in patients with CKD stages IV-V on pre-dialysis care.
- 11 August 2011
- Published by Springer Nature in BMC Nephrology
- Vol. 12 (1) , 38
Open AccessAssociation of blood pressure with decline in renal function and time until the start of renal replacement therapy in pre-dialysis patients: a cohort study
To investigate whether high blood pressure accelerates renal function decline in patients with advanced chronic kidney disease (CKD), we studied the association of systolic (SBP) and diastolic blood pressure (DBP) with decline in renal function and time until the start of renal replacement therapy (RRT) in patients with CKD stages IV-V on pre-dialysis care.
- 16 July 2010
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 26 (2) , 652-658
Association between time of referral and survival in the first year of dialysis in diabetics and the elderly
The objective of the study was to estimate the association between time of referral and survival during dialysis in diabetics and patients aged≥70 years. This study was a prospective follow-up study in 1438 incident dialysis patients (1996-2004, 62% male, 60±15 years) in The Netherlands. Main outcome measures. Referral (time between first pre-dialysis visit to a nephrologist and dialysis initiation) was classified as: late (<3 months), early (3-12 months) or very early (≥12 months). All-cause mortality risk within the first year of dialysis was calculated [HR (95% confidence interval, CI), adjusted for age, sex and primary kidney disease (PKD)]. Additive interaction between time of referral and diabetes mellitus (adjusted for age and sex) or age (adjusted for sex and PKD) was assessed by synergy index [S (95% CI)]. Thirty-two percent were late referred, 12% early and 56% very early; 21% had diabetes; and 30% were ≥70 years. Early and late referrals were associated with increased mortality compared with very early referral [HRadjearly: 1.5 (1.0, 2.4), late: 1.8 (1.3, 2.5)]. A similar trend was observed in diabetics and non-diabetics. However, no interaction between time of referral and diabetes was present [Slate 0.8 (0.4, 1.9), Searly 1.2 (0.4, 3.6)]. Likewise, in patients aged<70 and ≥70 years, time of referral was associated with increased mortality, without interaction [Slate 0.9 (0.4, 1.8), Searly 0.8 (0.3, 2.0)]. Late referral is associated with increased mortality in the first year of dialysis. Diabetes or high age does not have an additional worsening effect, implying that timely referral is important in future dialysis patients irrespective of diabetes or high age.
- 16 July 2010
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 26 (2) , 652-658
Association between time of referral and survival in the first year of dialysis in diabetics and the elderly
The objective of the study was to estimate the association between time of referral and survival during dialysis in diabetics and patients aged≥70 years. This study was a prospective follow-up study in 1438 incident dialysis patients (1996-2004, 62% male, 60±15 years) in The Netherlands. Main outcome measures. Referral (time between first pre-dialysis visit to a nephrologist and dialysis initiation) was classified as: late (<3 months), early (3-12 months) or very early (≥12 months). All-cause mortality risk within the first year of dialysis was calculated [HR (95% confidence interval, CI), adjusted for age, sex and primary kidney disease (PKD)]. Additive interaction between time of referral and diabetes mellitus (adjusted for age and sex) or age (adjusted for sex and PKD) was assessed by synergy index [S (95% CI)]. Thirty-two percent were late referred, 12% early and 56% very early; 21% had diabetes; and 30% were ≥70 years. Early and late referrals were associated with increased mortality compared with very early referral [HRadjearly: 1.5 (1.0, 2.4), late: 1.8 (1.3, 2.5)]. A similar trend was observed in diabetics and non-diabetics. However, no interaction between time of referral and diabetes was present [Slate 0.8 (0.4, 1.9), Searly 1.2 (0.4, 3.6)]. Likewise, in patients aged<70 and ≥70 years, time of referral was associated with increased mortality, without interaction [Slate 0.9 (0.4, 1.8), Searly 0.8 (0.3, 2.0)]. Late referral is associated with increased mortality in the first year of dialysis. Diabetes or high age does not have an additional worsening effect, implying that timely referral is important in future dialysis patients irrespective of diabetes or high age.
- Top Cited PapersOpen Access
- 28 October 2009
- Published by American Medical Association (AMA) in JAMA
- Vol. 302 (16) , 1782-1789
Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
Patients with chronic kidney disease are at higher mortality risk compared with the general population.1,2 Cardiovascular disease is the most common cause of death in these patients, as noted more than 30 years ago.3 Several studies have shown that cardiovascular disease accounts for 40% to 50% of deaths in patients with end-stage renal disease.4-6 Cardiovascular mortality risk in patients receiving hemodialysis or peritoneal dialysis is observed to be 10 to 20 times that in the general population.4,6
- 28 October 2009
- Published by American Medical Association (AMA) in JAMA
- Vol. 302 (16) , 1782-1789
Top Cited PapersOpen AccessCardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis
Patients with chronic kidney disease are at higher mortality risk compared with the general population.1,2 Cardiovascular disease is the most common cause of death in these patients, as noted more than 30 years ago.3 Several studies have shown that cardiovascular disease accounts for 40% to 50% of deaths in patients with end-stage renal disease.4-6 Cardiovascular mortality risk in patients receiving hemodialysis or peritoneal dialysis is observed to be 10 to 20 times that in the general population.4,6